Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Psychedelic / Peyote
Psychedelic

Peyote

Peyote is a small cactus containing the psychedelic mescaline, used for centuries as a sacred sacrament by Indigenous peoples and the Native American Church. Its effects come from mescaline and include strong nausea; its US legal status is notable for a genuine religious-use exemption alongside Schedule I control, and the plant is slow-growing and threatened.

Overview

Peyote (Lophophora williamsii) is a small, spineless, slow-growing cactus native to south Texas and northern Mexico. Its crown is harvested as "buttons" that are eaten fresh or dried, or brewed into a tea. It contains mescaline, a psychedelic phenethylamine, along with dozens of related alkaloids. Peyote has been used for centuries — likely millennia — as a sacred sacrament in the ceremonies of Indigenous peoples of the region, and it remains central to the religious practice of the Native American Church, whose members use it ceremonially today. It is both a psychoactive plant and, for many communities, a religious and cultural cornerstone.

Source: peer-reviewed and government sources (MedlinePlus; US DOJ)

Chemistry & mechanism of action

Peyote's psychoactive effects come from mescaline, its principal active alkaloid, which is present in the dried cactus at roughly 1 to 6 percent by weight. Mescaline is a classic serotonergic psychedelic that acts as an agonist at serotonin 5-HT2A receptors — the same mechanism underlying LSD, psilocybin, and the 2C compounds. Peyote also contains many other minor alkaloids, but mescaline is responsible for the characteristic psychedelic experience.

Source: peer-reviewed pharmacology literature

Effects

Peyote produces a long psychedelic experience — commonly on the order of 10 to 12 hours — including visual changes and enhancement, altered perception of time, emotional and introspective shifts, and, in ceremonial contexts, experiences described as spiritual. A very characteristic physical effect is pronounced nausea and vomiting, especially early in the experience, along with dilated pupils, raised heart rate and blood pressure, sweating, and sometimes headache or muscle weakness.

Source: peer-reviewed and government sources

Risks & harms

Peyote is not associated with physical dependence, and mescaline has low physiological toxicity, but it carries real risks. The intense and long-lasting psychological experience can be frightening or destabilizing, particularly for people with a personal or family history of psychosis or serious mental illness. The cardiovascular effects — raised heart rate and blood pressure — are a concern for people with heart conditions or high blood pressure. The strong nausea and vomiting are near-universal. As a serotonergic psychedelic, mescaline can interact with serotonergic medications. There is also a conservation dimension to harm: peyote is slow-growing and increasingly threatened by over-harvesting, which raises sustainability and cultural-preservation concerns distinct from personal health risk.

Source: peer-reviewed and government sources

Subjective effects

illusions, hallucinations, altered perception of space/time, altered body image, euphoria

Onset

0.5–0.9 hr

Duration

6–14 hr (dose-dependent)

Harmful effects

intense nausea, vomiting, pupil dilation, raised HR/BP, raised body temp + heavy perspiration, headache, muscle weakness, impaired coordination

Medicinal use

none approved

History

peyote used in religious rites by natives of N Mexico/SW US since earliest recorded time; mescaline isolated late 19th c.

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

With psychedelics, fear and confusion are usually temporary. Change your surroundings — calmer light, quiet music, a trusted person — and remind yourself it will lift as the drug wears off.

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

PubChem CID
N/A — no single PubChem compound (mixture/class/plant/concept)
IUPAC name
N/A — no single PubChem compound (mixture/class/plant/concept)
Molecular formula
N/A — no single PubChem compound (mixture/class/plant/concept)
SMILES
N/A — no single PubChem compound (mixture/class/plant/concept)
InChIKey
N/A — no single PubChem compound (mixture/class/plant/concept)
Synonyms / aliases
lophophora williamsii, mescal buttons

Composition

Composition
Unknown — pending review (no single compound; needs an epidemiology / composition source)

Physical / pill characteristics

Dosage form
Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
Route
Unknown — pending review
Shape
Unknown — pending review
Color
Unknown — pending review
Imprint
Unknown — pending review
Score
Unknown — pending review

Scheduling & legal status

US schedule
Unknown — pending review
International
See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA · retrieved 2026-06-18

Effects

Effects
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Risks

Risks
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Interactions

Interactions
Unknown — pending review

Dosage

Pending medical reviewer

Sources

← Back to the drug index